Based on the Globus Medical stock forecast from 11 analysts, the average analyst target price for Globus Medical is USD 95.95 over the next 12 months. Globus Medical’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Globus Medical is Slightly Bullish , which is based on 6 positive signals and 3 negative signals. At the last closing, Globus Medical’s stock price was USD 71.14. Globus Medical’s stock price has changed by -4.23% over the past week, +0.14% over the past month and +37.36% over the last year.
No recent analyst target price found for Globus Medical
No recent average analyst rating found for Globus Medical
Company Overview Globus Medical
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers musculoskeletal solutions, including spine products, such as traditional fusion implants, and treatment options for motion preservation technologies, and interventional solutions to treat vertebral compression fractures; orthopedic trauma solutions, which includes fracture plating, intramedullary nailing, and regenerative biologic products; hip and knee joint solutions, including modular hip stems and acetabular cups for total hip arthroplasty, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants; and neuromonitoring services, which provides onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company also offers enabling technologies, such as imaging, navigation, and robotics (INR) solutions for assisted surgery, which includes the ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures with screw and interbody spacer placement applications; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative, image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cell, tissue, and cellular and tissue-based products. The company sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania. Read Less
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers musculoskeletal solutions, including spine products, such as traditional fusio...Read More
Frequently Asked Questions About Globus Medical (GMED) Stock
Based on ratings from 11 analysts Globus Medical's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 16 buy, sell and 4 hold ratings.
Unfortunately we do not have enough data on GMED's stock to indicate if its a good dividend stock.
Based on targets from 11 analysts, the average taret price for GMED is USD 95.95 over the next 12 months. The maximum analyst target price is USD 115 while the minimum anlayst target price is USD 82.
GMED stock's Price/Earning ratio is 94.72.
Our analysis grades GMED stock's Price / Earning ratio at F. This means that GMED stock's Price/Earning ratio is above 71% of the stocks in the Medical Devices sector in the NYE exchange.
Based on this GMED may be a overvalued for its sector.
The last closing price of GMED's stock was USD 71.14.
The most recent market capitalization for GMED is USD 9.77B.
Based on targets from 11 analysts, the average taret price for GMED is projected at USD 95.95 over the next 12 months.
This means that GMED's stock price may go up by +34.87% over the next 12 months.
We can't find any ETFs which contains Globus Medical's stock.
As per our most recent records Globus Medical has 5,300 Employees.
Globus Medical's registered address is 2560 General Armistead Avenue, Audubon, PA, United States, 19403.
You can get more information about it from Globus Medical's website at https://www.globusmedical.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Globus Medical (GMED) Stock
Based on ratings from 11 analysts Globus Medical's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 16 buy, sell and 4 hold ratings.
Unfortunately we do not have enough data on GMED's stock to indicate if its a good dividend stock.
Based on targets from 11 analysts, the average taret price for GMED is USD 95.95 over the next 12 months. The maximum analyst target price is USD 115 while the minimum anlayst target price is USD 82.
GMED stock's Price/Earning ratio is 94.72.
Our analysis grades GMED stock's Price / Earning ratio at F. This means that GMED stock's Price/Earning ratio is above 71% of the stocks in the Medical Devices sector in the NYE exchange.
Based on this GMED may be a overvalued for its sector.
The last closing price of GMED's stock was USD 71.14.
The most recent market capitalization for GMED is USD 9.77B.
Based on targets from 11 analysts, the average taret price for GMED is projected at USD 95.95 over the next 12 months.
This means that GMED's stock price may go up by +34.87% over the next 12 months.
We can't find any ETFs which contains Globus Medical's stock.
As per our most recent records Globus Medical has 5,300 Employees.
Globus Medical's registered address is 2560 General Armistead Avenue, Audubon, PA, United States, 19403.
You can get more information about it from Globus Medical's website at https://www.globusmedical.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for GMED !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
